Related Experiment Video
Updated: Sep 21, 2026

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer
1The University of Texas M.D. Anderson Cancer Center, Houston, USA.
Abstract:
Despite increasing reports of life-threatening Fusarium infections, little is known about its pathogenesis and management. To evaluate the epidemiology, clinicopathologic features, and outcome of invasive fusariosis in patients with hematologic cancer, we conducted a retrospective study of invasive fusarial infections in patients with hematologic malignancy treated at a referral cancer center over a 10-year period (1986 to 1995), as well as a literature review. Forty patients with disseminated and three patients with invasive lung infection were included in the analysis. All patients were immunocompromised. The infection occurred in three patients postengraftment following bone marrow transplantation. All patients were diagnosed antemortem. Thirteen patients responded to therapy, but the infection relapsed in two of them. Response was associated with granulocyte transfusions, amphotericin B lipid formulations (four patients each), and an investigational triazole (two patients). Resolution of infection was only seen in patients who ultimately recovered from myelosuppression. Portal of entry was the skin (33%), the sinopulmonary tree (30%), and unknown (37%). Fusarium causes serious morbidity and mortality, and may mimic aspergillosis. The infection seems to respond to newer therapeutic approaches, but only in patients with ultimate recovery from myelosuppression, and it may relapse if neutropenia recurs.
Insights
Fusarium infections are dangerous in immunocompromised patients, particularly those with hematologic cancers. Recovery depends on overcoming myelosuppression, with potential for relapse if neutropenia returns.
Area of Science:
- Mycology
- Hematology
- Infectious Diseases
Background:
- Fusarium infections pose significant risks, yet their pathogenesis and management remain poorly understood.
- Invasive fusariosis is a life-threatening opportunistic infection in immunocompromised individuals.
Purpose of the Study:
- To investigate the epidemiology, clinical features, and outcomes of invasive fusariosis in patients with hematologic malignancy.
- To identify factors associated with treatment response and patient survival.
Main Methods:
- Retrospective analysis of 43 patients with invasive fusariosis (hematologic malignancy) from 1986-1995.
- Inclusion of a literature review to supplement case data.
- Antemortem diagnosis was performed for all included patients.
Main Results:
- All patients were immunocompromised; 3 developed infection post-bone marrow transplantation.
- Skin and sinopulmonary tracts were common sites of infection.
- Thirteen patients responded to therapy, with responses linked to granulocyte transfusions, lipid formulations of amphotericin B, and an investigational triazole.
Conclusions:
- Invasive fusariosis presents serious morbidity and mortality in immunocompromised patients, potentially mimicking aspergillosis.
- Treatment response is contingent upon recovery from myelosuppression.
- Relapse can occur if neutropenia recurs, highlighting the importance of sustained immune recovery.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Cryptococcal Meningitis

